Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3(+) regulatory T cells

OBJECTIVES: Mesenchymal stem cells (MSCs) have shown great potential in treating autoimmune diseases (ADs). Unlike the traditional immunosuppressants, which inadvertently impair patients' antimicrobial immunity, MSCs reduce the incidence and duration of respiratory infection. However, the under...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenchao, Chen, Weiwei, Huang, Saisai, Yao, Genhong, Tang, Xiaojun, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526004/
https://www.ncbi.nlm.nih.gov/pubmed/33014369
http://dx.doi.org/10.1002/cti2.1181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526004/
https://www.ncbi.nlm.nih.gov/pubmed/33014369
http://dx.doi.org/10.1002/cti2.1181

Ejemplares similares